Total marketcap
Total volume
BTC 48.87%     ETH 17.18%

Sanofi SAN.PA Stock

89.55 EUR {{ price }} 0.912785% {{change_pct}}%
Market Cap
111.81B EUR
LOW - HIGH [24H]
88.48 - 89.59 EUR
527.74K EUR
{{ volume }}
P/E Ratio
Earnings per share
4.31 EUR

Sanofi Price Chart

Sanofi SAN.PA Financial and Trading Overview

Sanofi stock price 89.55 EUR
Previous Close 94.26 EUR
Open 94.98 EUR
Bid 0 EUR x 0
Ask 0 EUR x 0
Day's Range 94.78 - 95.37 EUR
52 Week Range 76.45 - 105.18 EUR
Volume 114.14K EUR
Avg. Volume 1.71M EUR
Market Cap 120.84B EUR
Beta (5Y Monthly) 0.416091
PE Ratio (TTM) 14.327819
EPS (TTM) 4.31 EUR
Forward Dividend & Yield 3.56 (3.79%)
Ex-Dividend Date May 30, 2023
1y Target Est 107.1 EUR

SAN.PA Valuation Measures

Enterprise Value 126.19B EUR
Trailing P/E 14.327819
Forward P/E 10.693603
PEG Ratio (5 yr expected) 1.5
Price/Sales (ttm) 2.6156573
Price/Book (mrq) 1.5959531
Enterprise Value/Revenue 2.731
Enterprise Value/EBITDA 8.767

Trading Information

Sanofi Stock Price History

Beta (5Y Monthly) 0.416091
52-Week Change 0.095%
S&P500 52-Week Change 20.43%
52 Week High 105.18 EUR
52 Week Low 76.45 EUR
50-Day Moving Average 99.42 EUR
200-Day Moving Average 90.09 EUR

SAN.PA Share Statistics

Avg. Volume (3 month) 1.71M EUR
Avg. Daily Volume (10-Days) 1.37M EUR
Shares Outstanding 1.25B
Float 1.1B
Short Ratio N/A
% Held by Insiders 11.39%
% Held by Institutions 43.73%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield 376.00%
Payout Ratio 0.5008
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023


Profit Margin 18.08%
Operating Margin (ttm) 24.42%
Gross Margin 69.93%
EBITDA Margin 31.15%

Management Effectiveness

Return on Assets (ttm) N/A
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 46.2B EUR
Revenue Per Share (ttm) 36.9 EUR
Quarterly Revenue Growth (yoy) 8.09%
Gross Profit (ttm) 31.7B EUR
Net Income Avi to Common (ttm) 8.36B EUR
Diluted EPS (ttm) 6.65
Quarterly Earnings Growth (yoy) -0.70%

Balance Sheet

Total Cash (mrq) 12.74B EUR
Total Cash Per Share (mrq) 10.2 EUR
Total Debt (mrq) 21.21B EUR
Total Debt/Equity (mrq) 28.23 EUR
Current Ratio (mrq) N/A
Book Value Per Share (mrq) 59.701

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of Sanofi

Country France
State N/A
City Paris
Address 46, avenue de la Grande Arm e
ZIP 75017
Phone 33 1 53 77 40 00
Website https://www.sanofi.com
Industry Drug Manufacturers-General
Sector(s) Healthcare
Full Time Employees 91573

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Q&A For Sanofi Stock

What is a current SAN.PA stock price?

Sanofi SAN.PA stock price today per share is 89.55 EUR.

How to purchase Sanofi stock?

You can buy SAN.PA shares on the Paris exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Sanofi?

The stock symbol or ticker of Sanofi is SAN.PA.

Which industry does the Sanofi company belong to?

The Sanofi industry is Drug Manufacturers-General.

How many shares does Sanofi have in circulation?

The max supply of Sanofi shares is 1.25B.

What is Sanofi Price to Earnings Ratio (PE Ratio)?

Sanofi PE Ratio is 20.77726400 now.

What was Sanofi earnings per share over the trailing 12 months (TTM)?

Sanofi EPS is 4.31 EUR over the trailing 12 months.

Which sector does the Sanofi company belong to?

The Sanofi sector is Healthcare.

Sanofi SAN.PA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
Euronext 100 Index N100 1468.47 EUR 1607.17 USD
1461.42 EUR 1599.45 USD 1468.86 EUR 1607.6 USD
ESTX 50 PR.EUR STOXX50E 4879.56 EUR 5340.44 USD
4850.32 EUR 5308.44 USD 4881.66 EUR 5342.74 USD
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD 2100.38 AUD 1410.69 USD
2100.38 AUD 1410.69 USD 2100.38 AUD 1410.69 USD
Nasdaq CRD Global Sustainabilit NQCRD 1735.62 USD
1715.94 USD 1757.95 USD
CAC 40 FCHI 7975.3 EUR 8728.58 USD
7907.84 EUR 8654.74 USD 7976.4 EUR 8729.78 USD
SBF 120 SBF120 6027.16 EUR 6596.43 USD
5979.67 EUR 6544.46 USD 6027.89 EUR 6597.23 USD
Nasdaq Developed Select Leaders NQDMSLC 1260.81 USD
1243.71 USD 1264.94 USD